QuantumPharm Inc
2228XtalPi Holdings Limited, an investment holding company, provides drug discovery and intelligent automation solutions in China, the United States, Europe, South Korea, and Japan. The company's drug discovery solutions cover the whole drug discovery and research process, including target validation, hit identification, lead generation, lead optimization, and PCC nomination covering various modalities, which comprise small molecules, antibodies, peptides, ADC, and PROTAC. Its intelligent automation solutions focus on AI- and automation-enabled novel drug and materials discovery and research. The company was formerly known as QuantumPharm Inc. and changed its name to XtalPi Holdings Limited in December 2024. XtalPi Holdings Limited was founded in 2015 and is headquartered in Shenzhen, China. Address: Second Phase of the International, Shenzhen, China
Analytics
主に工業および宝飾用の金属です。市場が不況を予想し、生産が低下すると、価値は下がります。宝飾品業界からの需要も不安定です。現在、プラチナは金よりも安く、それで作られたアイテムはエリートと見なされません。
80.62 HKD生産が消費をまかなえない場合、供給不足の脅威があります。物理的な金属の不足への恐れの中で、価格は上昇します。しかし、これが不況の予想とともに起こると、価格にはほとんど影響がありません。これは2008年と2023年に明確に見られました。
–配当利回り
–今年
去年
今四半期
前四半期
今年
去年
今四半期
前四半期
主要人物 2228
配当分析 2228
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–